LX Bioboost Plus Pre-filled Syringes Recalled for Sterility Assurance Failure
LX Bioboost Plus pre-filled syringes are being recalled because the manufacturer cannot assure the product meets sterility requirements. Consumers should stop using the product and consult their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for lack of sterility assurance in an injectable product. No hospitalizations or injuries reported; the hazard is theoretical based on product formulation. Classified as High per rubric criterion for risk-of-harm products without reported injury.
Plain-English summary
LX Bioboost Plus is a pre-filled syringe injectable containing multiple vitamins and amino acids, manufactured by Thrive Health and Wellness, LLC (Colorado). The product is being recalled due to lack of assurance of sterility.
The recall affects 102 syringes distributed nationwide in the United States. The affected lot numbers are H227226 (expiration 12/24/2025), H360175 (expiration 6/2/2025), H368308 (expiration 6/2/2025), and S360175 (expiration 6/2/2025).
Consumers who have received this product should stop using it immediately. Contact your healthcare provider if you have any questions or concerns about the use of this product.
The recalled product
- Product
- LX Bioboost Plus, (Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Pyridoxine HCl 25 mg, Dexpanthenol 25 mg, Cyanocobalamin 1 mg, L-Arginine HCl 15 mg, L-Carnitine 15 mg, and Lidocaine 1 mg in SWFI), pre-filled syringe, Thrive Health Solutions, 88 Inve
- Manufacturer
- Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
- Category
- Drug — Injectable Supplement
- Hazard
- sterility-failure
- contamination-risk
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: H227226
- Exp 12/24/2025
- H360175
- Exp 6/2/2025
- H368308
- Lot S360175
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27